secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2025-12-03T23:59:59+00:00
Accession:  0001731122-25-001625
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lunai Bioworks enters ATM sales agreement for up to $11.7M common stock offering
--------------------------------------------------------------------------------

- Agreement with Dawson James Securities for at-the-market offering of up to $11.7M in common stock.
- Sales Agent receives 3.0% commission on gross proceeds; reimbursed for certain expenses.
- Shares sold under effective S-3 registration statement (File No. 333-282898).
- Company not obligated to sell any shares; may suspend or terminate at any time with 10 days' notice.
- Net proceeds intended for general corporate purposes (per prospectus supplement).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225001625/0001731122-25-001625-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225001625/e7056_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-25-001625

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer